Increased Fanconi C expression contributes to the emergency granulopoiesis response

Journal of Clinical Investigation

Volumn 123, Issue 9, 2013, Pages 3952-3966

  Hu, Liping ^a   Huang, Weiqi ^a,b   Hjort, Elizabeth ^a   Eklund, Elizabeth A ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FANCONI ANEMIA PROTEIN; FANCONI C PROTEIN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERLEUKIN 1BETA; UNCLASSIFIED DRUG; FANCONI ANEMIA GROUP C PROTEIN; INTERFERON REGULATORY FACTOR; INTERLEUKIN 1 RECEPTOR; PROTEIN BINDING;

ANEMIA; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA REPLICATION; GENE ACTIVATION; GENOMIC INSTABILITY; GRANULOPOIESIS; HEMATOPOIETIC CELL; INNATE IMMUNITY; MOUSE; MYELOID PROGENITOR CELL; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL DIFFERENTIATION; DEFICIENCY; DNA REPAIR; DNA RESPONSIVE ELEMENT; FANCONI ANEMIA; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROMOTER REGION; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DNA REPAIR; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP C PROTEIN; GENE EXPRESSION; GENE EXPRESSION REGULATION; GRANULOCYTES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTORS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MYELOID CELLS; MYELOID PROGENITOR CELLS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTORS, INTERLEUKIN-1; RESPONSE ELEMENTS;

EID: 84883549557     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI69032     Document Type: Article

References (51)

1. Driggers PH, et al. An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci U S A . 1990;87(10):3743-3747.
2. Eklund EA, Jalava A, Kakar R. PU.1, interferon regulatory factor 1, and interferon consensus sequence binding protein cooperate to increase gp91phox expression. J Biol Chem. 1998;273(22):13957-13965. (Pubitemid 28268451)
3. Eklund EA, Kakar R. Recruitment of CBP by PU.1, IRF1 and ICSBP is necessary for gp91phox and p67phox expression. J Immunol . 1999; 163(11):6095-6105.
4. Kim YM, et al. Roles of IFN consensus sequence binding protein and PU.1 in regulating IL-18 gene expression. J Immunol. 1999;163(4):2000-2007.
5. Holtschke T, et al. Immuno-deficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell. 1996;87(2):307-317. (Pubitemid 26359008)
6. Konieczna I, et al. Constitutive activation of SHP2 cooperates with ICSBP-deficiency to accelerate progression to acute myeloid leukemia. J Clin Invest . 2008;118(3):853-867. (Pubitemid 351364594)
7. Ueda Y, Cain DW, Kuraoka M, Kondo M, Kelsoe G. IL1R type I dependent hematopoietic stem cell proliferation is necessary for inflammatory granulopoiesis and reactive neutrophilia. J Immunol . 2009;182(10):6477-6484.
8. Cain DW, Snowden PB, Sempowski GD, Kelsoe G. Inflammation triggers emergency granulopoiesis through a density-dependent feedback mechanism. PLoS One. 2011;6(5):e19957.
9. Hirai H, et al. C/EBPbeta is required for 'emergency' granulopoiesis. Nat Immunol. 2006;7(7):732-739.
10. Panopoulos AD, et al. Stat3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood. 2006;108(12):3682-3690. (Pubitemid 44864545)
11. Lieschke GJ, et al. Mice lacking G-CSF have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency and impaired neutrophil mobilization. Blood. 1994;84(6):1737-1746. (Pubitemid 24286121)
12. Zhan Y, Lieschke GJ, Grail D, Dunn AR, Cheers C. Essential roles for GM-CSF and G-CSF in the sustained hematopoietic response of Listeria monocytogenes infected mice. Blood. 1998;91(3):863-869. (Pubitemid 28078288)
13. Panopoulos AD, Watchwich SS. Granulocyte colony stimulating factor: molecular mechanisms of activation during steady state and emergency hematopoiesis. Cytokine. 2008;42(3):277-288.
14. Huang W, Saberwal G, Horvath E, Zhu C, Lindsey S, Eklund EA. Leukemia associated, constitutively active mutants of SHP2 protein tyrosine phosphatase inhibit NF1-transcriptional activation by the interferon consensus sequence binding protein. Mol Cell Biol. 2006;26(17):6311-6332. (Pubitemid 44277874)
15. Huang W, Zhu C, Wang H, Horvath E, Eklund EA. The interferon consensus sequence binding protein (ICSBP/IRF8) represses PTPN13 gene transcription in differentiating myeloid cells. J Biol Chem. 2008;283(12):7921-7935.
16. Huang W, et al. The Interferon consensus sequence binding protein (ICSBP) decreases beta-catenin activity in myeloid cells by repressing GAS2 transcription. Mol Cell Biol. 2010;30(19):4575-4594.
17. Saberwal G, Horvath E, Hu L, Zhu C, Hjort E, Eklund EA. The interferon consensus sequence binding protein (ICSBP/IRF8) activates transcription of the FANCF gene during myeloid differentiation. J Biol Chem. 2009;284(48):33242- 33254.
18. Moldovan GL, D'Andrea AD. How the fanconi anemia pathway guards the genome. Annu Rev Genet. 2009;43:223-249.
19. Kee Y, D'Andrea AD. Molecular pathogenesis and clinical management of Fanconi anemia. J Clin Invest. 2012;122(11):3799-3806.
20. Thompson LH, Hinz JM. Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights. Mut Res. 2009;668(1-2):54-72.
21. Li X, Heyer WD. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res. 2008;18(1):99-113.
22. Schlacher K, Wu H, Jasin M. A distinct replication fork protection pathway connects Fanconi Anemia tumor suppressors to Rad51-BrCA1/2. Cancer Cell. 2012;22(1):106-116.
23. Wang LC, Stone S, Hoatlin ME, Gautier J. Fanconi anemia proteins stabilize replication forks. DNA Repair (Amst). 2008;7(12):1973-1981.
24. Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, D'Andrea AD. S-phase specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood. 2002;100(7):2414-2420.
25. Auerbach AD, Allen RG. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogenet. 1991;51(1):1-12.
26. Cioc AM, Wagner JE, MacMillan ML, DeFor T, Hirsch B. Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with Fanconi Anemia. Am J Clin Pathol. 2010;133(1):92-100.
27. Wang H, et al. Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia. J Biol Chem. 2009;284(4):2549-2567.
28. Zhu CL, Saberwal G, Lu YF, Platanias LC, Eklund EA. The interferon consensus sequence binding protein (ICSBP) activates transcription of the gene encoding Neurofibromin 1 (NF1). J Biol Chem . 2004;279(49):50874-50885. (Pubitemid 40017826)
29. Scheller M, et al. Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. Blood. 1999;94(11):3764-3771.
30. Holtschke T, et al. Immuno-deficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell. 1996;87(2):307-317. (Pubitemid 26359008)
31. Kin JM, Kee Y, Gurtan A, D'Andrea AD. Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24. Blood. 2008;111(10):5215-5222.
32. Larrick JW, Fischer DG, Anderson SJ, Koren HA. Characterization of a human macrophage-like cell line stimulated to differentiate in vitro: a model of macrophage functions. J Immunol. 1980;125(1):6-12. (Pubitemid 10040389)
33. Levy DE, Kessler DS, Pine R, Reich N, Darnell JE Jr. Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev. 1988;2(4):383-393.
34. Chen M, et al. Inactivation of FANC in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi Anaemia. Nat Genet. 1996;12(4):448-451. (Pubitemid 26105940)
35. Carreau M, Gan OI, Liu L, Doedens M, Dick JE, Buchwald M. Hematopoietic compartment of Fanconi anemia group C null mice contains fewer lineage-negative CD34+ primitive hematopoietic cells and shows reduced reconstruction ability. Exp Hematol. 1999;27(11):1667-1674. (Pubitemid 29526751)
36. Carreau M, et al. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage. Blood. 1998;91(8):2737-2744. (Pubitemid 28227523)
37. Freie B, et al. Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis. Blood. 2003;102(12):4146-4152. (Pubitemid 37487001)
38. Kool M, et al. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol. 2008;181(6):3755-3759.
39. Basu S, Hodgson G, Zhang HH, Katz M, Quilici C, Dunn AR "Emergency" granulopoiesis in G-CS-F-deficient mice in response to Candida albicans infection. Blood. 2000;95(12):3725-3733. (Pubitemid 30412843)
40. Zhan Y, Lieschke GJ, Grail D, Dunn AR, Cheers C. Essential roles for GM-CSF and G-CSF in the sustained hematopoietic response of Listeria monocytogenes infected mice. Blood. 1998;91(3):863-869. (Pubitemid 28078288)
41. Ueda Y, Yang K, Foster SJ, Kondo M, Kelsoe G. Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression. J Exp Med. 2004;199(1):47-58.
42. Arend WP. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest. 1991;88(5):1445-1451.
43. Fleishmann RM. Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-alpha agents. Clin Exp Rheumatol. 2002;20(5 suppl 27):S35-S41. (Pubitemid 35174752)
44. de Oliveira-Junior EB, Bustamante J, Newburger PE, Condino-Neto A. The human NADPH oxidase; primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes. Scand J Immunol. 2011;73(5):420-427.
45. Rathbun RK, et al. Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells. Blood. 1997;90(3):974-985. (Pubitemid 27314130)
46. Haneline LS, et al. Multiple inhibotry cytokines induce deregulated progenitor growtn and apoptosis in hematopietic cells from Fanc-/- mice. Blood. 1998;91(11):4092-4098. (Pubitemid 28261970)
47. Kang KW, Kim TS, Kim KM. Interferon gamma and interleukin 4 targeted gene therapy for atopic allergic disease. Immunology. 1999;97(3):462-465. (Pubitemid 29314643)
48. Ibáñez A, Río P, Casado JA, Bueren JA, Fernández- Luna JL, Pipaón C. Elevated levels of IL-1beta in Fanconi anaemia group A patients due to a constitutively active phosphoinositide 3-kinase-Akt pathway are capable of promoting tumour cell proliferation. Biochem J. 2009;422(1):161-170.
49. Surguladze D, et al. Tumor necrosis factor-alpha and interleukin-1 antagonists alleviate inflammatory skin changes associated with epidermal growth factor receptor antibody therapy in mice. Cancer Res. 2009;69(14):5643-5647.
50. Mayor C, et al. VISTA: visualizing global DNA sequence alignments of arbitrary length. Bioinformatics. 2000;16(11):1046-1047. (Pubitemid 32051021)
51. Loots G, Ovcharenko I, Pachter L, Dubchak I, Rubin EM. rVista for comparative sequence-based discovery of functional transcription factor binding sites. Genome Res. 2002;12(5):832-839. (Pubitemid 34546471)